Dr Reddy’s Continues To Capitalize On German Cannabinoids With MediCane Launch
Company Will Launch A Portfolio Of Medical Cannabis Products Across Germany
Dr Reddy's has announced that it will market MediCane’s medical cannabis portfolio across Germany, as part of a collaboration between the two companies which began last year.
You may also be interested in...
Plantwise launched its CBD supplements in independent pharmacies in May with consultation consumers might not receive at larger chains.
Plus deals involving Shionogi/NEC, Ji Xing/LENZ, Kyowa Kirin/Ardelyx, CR Pharma/Everest Medicine and Dr Reddy’s/Novartis.
Dr Reddy’s enters high-potential medical cannabis fray with the acquisition of Nimbus Health in Germany. The segment has seen a flurry of activity over the recent past, including the $7.2bn acquisition of pioneer GW Pharmaceuticals.